SLC5A2 and hyperuricemia: Hyperuricemia in addition causing gout, is also independently associated with increased risk of cardiovascular outcomes.19 Reduction of serum uric acid levels has been seen with SGLT2 inhibitors due to increased urinary excretion.20 In our study, we observed a statistically nonsignificant slight decrease of serum uric acid levels.